Ledger.Open graph →
SEC Form D · filed November 18, 2021

Siduma Therapeutics, Inc

Offering
$31.2M
Sold
$31.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Rebecca Frey · Madison, CTDirectorCraig Crews · New Haven, CTExec · DirectorTimothy Shannon · Westport, CTDirectorJake Van · Fort Collins, COExec · DirectorDavid J. Freibaum · BOSTON, MADirectorKevin Brennan · BOCA RATON, FLDirectorAlejandro Palma · San Diego, CAExec · DirectorTimothy Shannon · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗